Skip to content

Ipsen: sector benchmark

Where does a company stand against its sector? Every ratio over five fiscal years, with its place among its peers and what that means, ready to print for your client.

Sector benchmark

Ipsen

BE 0422.650.477
NACE 46.460, Wholesale of pharmaceutical and medical goods
NACE division 46, Wholesale trade all sizesfiscal years 2021 to 20252,603 to 24,123 sector peers per ratio

Summary

fiscal year 2025

Ipsen does better than half of its sector on 9 of the 13 ratios compared.

most favourable quarter above the median below the median least favourable quarter
Strongest points
  • Working-capital ratiobetter than 95%
  • Quick ratiobetter than 91%
  • Current ratiobetter than 91%
Points to watch
  • Days inventorybetter than 23%
  • Return on equitybetter than 34%
  • Days sales outstandingbetter than 40%

Solvency and debt

How soundly the company is financed.
Solvency
89.2%▼2025

Solvency is above 90% of 24,039 sector peers: in the most favourable quarter.

Position against the sector stable since 2021.

20212022202320242025
Debt to equity
0.12▲2025

Debt to equity is below 78% of 23,857 sector peers: in the most favourable quarter.

Position against the sector stable since 2021.

20212022202320242025
Interest coverage
36.15▼2025

Interest coverage is above 75% of 20,995 sector peers: in the most favourable quarter.

Position against the sector stable since 2021.

20212022202320242025

Liquidity

Whether it can pay its short-term bills.
Current ratio
9.27▼2025

The current ratio is above 91% of 23,820 sector peers: in the most favourable quarter.

Position against the sector stable since 2021.

20212022202320242025
Quick ratio
8.34▼2025

The quick ratio is above 91% of 23,837 sector peers: in the most favourable quarter.

Position against the sector stable since 2021.

20212022202320242025
Working-capital ratio
88.9%▼2025

The working-capital ratio is above 95% of 24,002 sector peers: in the most favourable quarter.

Position against the sector stable since 2021.

20212022202320242025

Profitability

What the company earns on its assets and its sales.
Return on equity
3.5%▲2025

Return on equity is below 66% of 20,915 sector peers: less favourable than the median.

Position against the sector improving since 2021.

20212022202320242025
Return on assets
3.1%▲2025

Return on assets is below 52% of 24,123 sector peers: less favourable than the median.

Position against the sector improving since 2021.

20212022202320242025
Net margin
5.8%▲2025

The net margin is above 76% of 3,075 sector peers: in the most favourable quarter.

Position against the sector improving since 2021.

20212022202320242025
EBITDA margin
4.9%▲2025

The EBITDA margin is above 53% of 2,802 sector peers: more favourable than the median.

Position against the sector improving since 2021.

20212022202320242025
Gross margin
46.5%▲2025

The gross margin is above 86% of 2,983 sector peers: in the most favourable quarter.

Position against the sector stable since 2021.

20212022202320242025

Working-capital cycle

How long cash is tied up in customers, suppliers and stock.
Days sales outstanding
58days▲2025

Days sales outstanding is above 60% of 3,038 sector peers: less favourable than the median.

Position against the sector weakening since 2021.

20212022202320242025
Days payable outstanding
111days▲2025

Days payable outstanding is above 81% of 3,077 sector peers.

20212022202320242025
Days inventory
129days▲2025

Days inventory is above 77% of 2,603 sector peers: in the least favourable quarter.

Position against the sector weakening since 2021.

20212022202320242025

Not computable

Long-term debt ratio. The filed figures do not contain the lines these need.

Source: filed annual accounts (NBB) and main activity (CBE register). Compared per fiscal year with each peer's latest statutory accounts; at least 30 peers per ratio. Prepared on 28 September 2026 via checked.be.